{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:35:30Z","timestamp":1769074530187,"version":"3.49.0"},"reference-count":0,"publisher":"Portland Press Ltd.","issue":"6","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1984,6,1]]},"abstract":"<jats:p>1. Four boys with classical nephrogenic diabetes insipidus have been treated by indomethacin, by hydrochlorothiazide, and by the combination of indomethacin and hydrochlorothiazide.<\/jats:p>\n               <jats:p>2. Hydrochlorothiazide treatment was slightly more effective than indomethacin treatment in reducing the urine volume and increasing the urine osrnolality.<\/jats:p>\n               <jats:p>3. The combination of indomethacin and hydrochlorothiazide appeared to be additive and especially helpful in infants and young children before the autonomy of drinking.<\/jats:p>","DOI":"10.1042\/cs0660709","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T10:50:35Z","timestamp":1438944635000},"page":"709-715","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus"],"prefix":"10.1042","volume":"66","author":[{"given":"L.","family":"Monnens","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jonkman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of Nijmegen, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/66\/6\/709\/513395\/cs0660709.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/66\/6\/709\/513395\/cs0660709.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T21:18:14Z","timestamp":1638479894000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/66\/6\/709\/98303\/Response-to-indomethacin-and-hydrochlorothiazide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,6,1]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1984,6,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs0660709","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,6,1]]}}}